Literature DB >> 10810997

The role of inflammation in vascular diseases.

G W Sullivan1, I J Sarembock, J Linden.   

Abstract

When the body responds to an infectious insult, it initiates an immune response to eliminate the pathogen. The hallmark of the immune response is an inflammatory cascade that can also do extensive damage to host tissues. Inflammation is a major contributing factor to many vascular events, including atherosclerotic plaque development and rupture, aortic aneurysm formation, angiogenesis, and ischemia/reperfusion damage. The immune response is mediated by both circulating and resident leukocytes and the cells with which they interact (e.g., vascular endothelium and smooth muscle cells). The process is orchestrated by the activity of a changing series of released and displayed mediators. These include the expression of adhesion molecules on leukocytes and underlying vascular endothelium and the release of cytokines, chemokines, and tissue-destructive metalloproteases and reactive oxygen species. This review focuses on the causes, the inflammatory processes involved, and possible strategies for decreasing vascular disease through regulation of the inflammatory response.

Entities:  

Mesh:

Year:  2000        PMID: 10810997     DOI: 10.1002/jlb.67.5.591

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  54 in total

Review 1.  Renal ischemia--reperfusion injury: an inescapable event affecting kidney transplantation outcome.

Authors:  R Böhmová; O Viklický
Journal:  Folia Microbiol (Praha)       Date:  2001       Impact factor: 2.099

2.  Differential effect of Fc gamma receptor ligation on LPS-stimulated TNF-alpha secretion by hepatic, splenic, and peritoneal macrophages.

Authors:  Daniel J Loegering; Michelle R Lennartz
Journal:  Inflammation       Date:  2002-12       Impact factor: 4.092

Review 3.  Multi-bed vascular disease: past, present, and future.

Authors:  William C Dixon; Robert A Harrington
Journal:  J Thromb Thrombolysis       Date:  2004-02       Impact factor: 2.300

4.  Kruppel-like factor 15 is critical for vascular inflammation.

Authors:  Yuan Lu; Lisheng Zhang; Xudong Liao; Panjamaporn Sangwung; Domenick A Prosdocimo; Guangjin Zhou; Alexander R Votruba; Leigh Brian; Yuh Jung Han; Huiyun Gao; Yunmei Wang; Koichi Shimizu; Kaitlyn Weinert-Stein; Maria Khrestian; Daniel I Simon; Neil J Freedman; Mukesh K Jain
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

5.  Protective effect of melatonin and omeprazole against alendronat-induced gastric damage.

Authors:  Goksel Sener; Figen Onuk Goren; Nefise B Ulusoy; Yasemin Ersoy; Serap Arbak; Gül Ayanoglu Dülger
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

6.  Atheroma and the inflammasome.

Authors:  H William Strauss
Journal:  J Nucl Cardiol       Date:  2015-02-20       Impact factor: 5.952

7.  Signaling pathways for Fc gamma receptor-stimulated tumor necrosis factor-alpha secretion and respiratory burst in RAW 264.7 macrophages.

Authors:  Daniel J Loegering; Michelle R Lennartz
Journal:  Inflammation       Date:  2004-02       Impact factor: 4.092

8.  Methanol extract of Ocimum gratissimum protects murine peritoneal macrophages from nicotine toxicity by decreasing free radical generation, lipid and protein damage and enhances antioxidant protection.

Authors:  Santanu Kar Mahapatra; Subhankari Prasad Chakraborty; Subhasis Das; Somenath Roy
Journal:  Oxid Med Cell Longev       Date:  2009 Sep-Oct       Impact factor: 6.543

9.  Comparison of serum apolipoprotein A-I between Chinese multiple sclerosis and other related autoimmune disease.

Authors:  Bin Zhang; ShuXiang Pu; BinMei Li; JianRui Ying; Xing Wang Song; Cong Gao
Journal:  Lipids Health Dis       Date:  2010-03-29       Impact factor: 3.876

10.  Proinflammatory cytokines in a mouse model of central retinal artery occlusion.

Authors:  Michal Kramer; S Dadon; M Hasanreisoglu; Y Monselise; B R Avraham; A Feldman; I Eldar; D Weinberger; N Goldenberg-Cohen
Journal:  Mol Vis       Date:  2009-05-01       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.